8-K - PHR - Equibles

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

________________________________________

FORM 8-K

________________________________________

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported)

December 8, 2020

________________________________________

Phreesia, Inc.

(Exact name of registrant as specified in its charter)

________________________________________

Delaware	001-38977	20-2275479
(State or other jurisdiction of<br>incorporation or organization)	(Commission<br>File Number)	(I.R.S. Employer<br>Identification Number)

432 Park Avenue South, 12th Floor

New York, New York 10016

(Address of principal executive offices and zip code)

(888) 654-7473

(Registrant’s telephone number, including area code)

________________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading<br>symbol(s)	Name of each exchange<br>on which registered
Common Stock, par value $0.01 per share	PHR	The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On December 8, 2020, the Company announced that Thomas Altier intends to retire from the role of Chief Financial Officer at the end of April 2021 after the filing of the Company’s Form 10-K following over eight years as Chief Financial Officer of the Company. Mr. Altier plans to remain as an advisor to the Company thereafter.

The Company also announced that Randy Rasmussen, age 48, will succeed Mr. Altier as the Company's new Chief Financial Officer in May 2021. Mr. Rasmussen has served as Chief Accounting Officer since November 2019. From May 2016 until October 2019, he served as Senior Vice President and Controller of Medidata Solutions, a cloud software company that provides a platform for clinical trials. From May 2005 until May 2016, Mr. Rasmussen was at SAP, S.E. most recently as VP Finance. Mr. Rasmussen began his career with Coopers & Lybrand,(now PwC) after receiving his bachelor's degree in Accounting and Finance from the University of Colorado at Boulder. He is also a Certified Public Accountant.

The Company has yet to finalize an offer letter with Mr. Rasmussen. There are no arrangements or understandings between Mr. Rasmussen and any other persons pursuant to which he was appointed as the Chief Financial Officer of the Company. There are no family relationships between Mr. Rasmussen and any director, executive officer or any person nominated or chosen by the Company to become a director or executive officer. No information is required to be disclosed with respect to Mr. Rasmussen pursuant to Item 404(a) of Regulation S-K.

A copy of the press release announcing the Chief Financial Officer transition is attached hereto as Exhibit 99.1.

Item 9.01 – Financial Statements and Exhibits

(d) Exhibits

Exhibit<br>Number	Description
99.1	Press release, dated December 8, 2020, by Phreesia, Inc.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: December 8, 2020	Phreesia, Inc.
	By:	/s/ Thomas Altier
	Name:	Thomas Altier
	Title:	Chief Financial Officer

Document

Phreesia Announces Planned CFO Transition in 2021: Chief Financial Officer Tom Altier to Retire, Randy Rasmussen Named New CFO

NEW YORK, Dec. 8, 2020 -- Phreesia, Inc. (NYSE: PHR) today announced that Tom Altier, its Chief Financial Officer, will retire in April 2021. Randy Rasmussen, the company’s Chief Accounting Officer, will succeed Altier as CFO, effective May 1, 2021. Altier, who joined Phreesia in 2012, will continue in his current role through the end of April 2021 and the filing of Phreesia’s Annual Report on Form 10-K, and thereafter will continue to support the company in an advisory role.

“Tom’s leadership has played a critical role in the success of our finance organization and of Phreesia as a whole, including during our transition to a public company” said Phreesia CEO Chaim Indig. “We deeply appreciate the work he has done to help further our mission and the indelible impact he has left on our team. Randy is bringing tremendous value to Phreesia and we’re so pleased that he will be our new CFO.”

Altier’s career spans more than 40 years in finance, including as CFO at Perspective Pixel, which was acquired by Microsoft in 2012, and other financial leadership roles. He began his career at Price Waterhouse (now PwC). Altier is a Certified Public Accountant and holds a BA and an MBA from Columbia University.

“It has been a privilege to work alongside our fantastic leadership team, board of directors and employees during my tenure at Phreesia,” said Altier, “Randy is doing an excellent job leading our accounting organization and I am confident that with his deep expertise, the company will be well-positioned for continued growth.”

Rasmussen joined Phreesia as CAO in November 2019. He has more than 25 years of finance and accounting experience, including multiple leadership roles at public companies of various sizes and stages of growth and evolution. Most recently, he was a Senior Vice President and Controller with Medidata Solutions, Inc. (NASDAQ: MDSO) where he managed global accounting operations, including SEC reporting and global financial planning and analysis. Prior to his role with Medidata, he spent over a decade in finance and accounting leadership roles with SAP SE (NYSE: SAP). Rasmussen began his career with Coopers & Lybrand (now PwC) after receiving his bachelor’s degree in Accounting and Finance from the University of Colorado at Boulder. He is also a Certified Public Accountant.

ABOUT PHREESIA

Phreesia gives healthcare organizations a suite of robust applications to manage the patient intake process. Our innovative SaaS platform engages patients and provides a modern, convenient experience, while enabling our clients to optimize their staffing, boost profitability and enhance clinical care. To learn more, visit phreesia.com

Phreesia

Maureen McKinney

212-457-0257

mmckinney@phreesia.com

ACTIVE/106083179.2